Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for hypomyelination-cerebellar atrophy-hypoplasia of the corpus callosum syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for hypomyelination-cerebellar atrophy-hypoplasia of the corpus callosum syndrome.
6 publications have been identified in PubMed for hypomyelination-cerebellar atrophy-hypoplasia of the corpus callosum syndrome. Research spans Case Report / Case Series (67%), Diagnostic / Biomarker (17%), and Epidemiology / Natural History (17%).
Zhou M (2026). [PMID: 41716259](https://pubmed.ncbi.nlm.nih.gov/41716259/). *Front Genet*. [Case Report / Case Series]
Paucar M (2025). [PMID: 39831730](https://pubmed.ncbi.nlm.nih.gov/39831730/). *Mov Disord*. [Case Report / Case Series]
Oikarainen JH (2025). [PMID: 39080972](https://pubmed.ncbi.nlm.nih.gov/39080972/). *Dev Med Child Neurol*. [Diagnostic / Biomarker]
Kaur N (2025). [PMID: 39470296](https://pubmed.ncbi.nlm.nih.gov/39470296/). *Am J Med Genet A*. [Epidemiology / Natural History]
Marsili L (2025). [PMID: 40498034](https://pubmed.ncbi.nlm.nih.gov/40498034/). *Mov Disord Clin Pract*. [Case Report / Case Series]
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 8:36 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Kraoua I (2024). [PMID: 39436788](https://pubmed.ncbi.nlm.nih.gov/39436788/). *Mol Genet Genomic Med*. [Case Report / Case Series]